Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Retinoblastoma × Observation × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Oropharyngeal Neoplasms 2 Multiple Myeloma 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tongue Neoplasms 1 Retinoblastoma 1 Recurrence 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Osteoporosis 1 Obesity 1 Neoplasms 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1

Interventions

Carboplatin 8 Etoposide 7 Vincristine 6 Filgrastim 5 Cyclophosphamide 5 Thiotepa 3 Topotecan 2 Temozolomide 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Mesna 2 Doxorubicin 2 Cryotherapy 2 Cisplatin 2 trioctyl phosphine oxide 1 pegfilgrastim 1 cixutumumab 1 becatecarin 1 abemaciclib 1 Ranibizumab 1 Proton Therapy 1 Observation 1 Methotrexate 1 Melphalan 1 Leucovorin 1 LY2940680 1 Immunologic Techniques 1 Granulocyte Colony-Stimulating Factor 1 Eye Enucleation 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡